HMG-CoA Reductase Inhibitor Therapy and Peripheral Neuropathy

Annals of Internal Medicine ◽

10.7326/0003-4819-120-11-199406010-00013 ◽

1994 ◽

Vol 120 (11) ◽

pp. 970 ◽

Author(s):

Michael B. Jacobs

Keyword(s):

Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Inhibitor Therapy ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data

Atherosclerosis ◽

10.1016/s0021-9150(98)00014-8 ◽

1998 ◽

Vol 138 (1) ◽

pp. 11-24 ◽

Author(s):

John R Crouse III ◽

Robert P Byington ◽

Curt D Furberg

Keyword(s):

Clinical Trials ◽

Risk Reduction ◽

Reductase Inhibitor ◽

Stroke Risk ◽

Inhibitor Therapy ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

HMG CoA reductase inhibitor therapy underused after CAGB

PharmacoEconomics & Outcomes News ◽

10.1007/bf03279119 ◽

2002 ◽

Vol 364 (1) ◽

pp. 8-8

Keyword(s):

Reductase Inhibitor ◽

Inhibitor Therapy ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Pluripotential Mechanisms of Cardioprotection with HMG-CoA Reductase Inhibitor Therapy

American Journal of Cardiovascular Drugs ◽

10.2165/00129784-200101060-00001 ◽

2001 ◽

Vol 1 (6) ◽

pp. 411-420 ◽

Author(s):

Robert S. Rosenson

Keyword(s):

Reductase Inhibitor ◽

Inhibitor Therapy ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Muscle pains and/or CK-elevation during HMG-CoA-reductase inhibitor therapy are frequently associated with increased isoprostane

Atherosclerosis ◽

10.1016/s0021-9150(00)80171-9 ◽

2000 ◽

Vol 151 (1) ◽

pp. 38

Author(s):

H Sinzinger ◽

Graziana Lupattelli ◽

F Chehne ◽

A Oguogho ◽

C.D Furberg

Keyword(s):

Reductase Inhibitor ◽

Inhibitor Therapy ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Low-dose HMG-CoA reductase inhibitor therapy in gemfibrozil-treated dyslipidemic diabetic patients with CAD

Atherosclerosis ◽

10.1016/0021-9150(94)93976-4 ◽

1994 ◽

Vol 109 (1-2) ◽

pp. 244

Author(s):

S.R. Crespin

Keyword(s):

Reductase Inhibitor ◽

Low Dose ◽

Inhibitor Therapy ◽

Diabetic Patients ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

HMG CoA reductase inhibitor therapy reduces stroke risk

Inpharma Weekly ◽

10.1007/bf03315208 ◽

1997 ◽

Vol 1093 (1) ◽

pp. 16-16

Keyword(s):

Reductase Inhibitor ◽

Stroke Risk ◽

Inhibitor Therapy ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Effect of long-term HMG-CoA-reductase inhibitor therapy on large artery endothelial function and distensibility after kidney transplantation

American Journal of Hypertension ◽

10.1016/s0895-7061(03)00453-9 ◽

2003 ◽

Vol 16 (5) ◽

pp. A141

Author(s):

U HILLEBRANDT

Keyword(s):

Kidney Transplantation ◽

Endothelial Function ◽

Reductase Inhibitor ◽

Inhibitor Therapy ◽

Large Artery ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Cost-Effectiveness of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitor Therapy in the Managed Care Era

The American Journal of Cardiology ◽

10.1016/s0002-9149(96)00660-1 ◽

1996 ◽

Vol 78 (6) ◽

pp. 32-41 ◽

Author(s):

Terry A Jacobson

Keyword(s):

Cost Effectiveness ◽

Managed Care ◽

Reductase Inhibitor ◽

Inhibitor Therapy ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Download Full-text

Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy.

The Journal of Lipid Research ◽

10.1016/s0022-2275(20)39941-7 ◽

1994 ◽

Vol 35 (11) ◽

pp. 1946-1955

Author(s):

M Pfohl ◽

R P Naoumova ◽

C Klass ◽

W Knisel ◽

B Jakober ◽

...

Keyword(s):

Reductase Inhibitor ◽

Cholesterol Biosynthesis ◽

Inhibitor Therapy ◽

Ldl Apheresis ◽

Hmg Coa Reductase ◽

Chronic Effects ◽

Hmg Coa Reductase Inhibitor ◽

Coa Reductase ◽

Acute And Chronic Effects

Download Full-text

Myopathy/rhabdomyolysis in patients after heart transplantation by presurgical treatment with lipid-lowering drugs? Interaction of cyclosporine and HMG-CoA reductase inhibitor therapy?

Neuromuscular Disorders ◽

10.1016/s0960-8966(97)87239-2 ◽

1997 ◽

Vol 7 (6-7) ◽

pp. 446 ◽

Author(s):

U.P. Ketelsen ◽

D. Trenk ◽

E.M. Eschenbruch ◽

P.J. Tollenaere

Keyword(s):

Heart Transplantation ◽

Reductase Inhibitor ◽

Inhibitor Therapy ◽

Lipid Lowering ◽

Hmg Coa Reductase ◽

Lipid Lowering Drugs ◽

Hmg Coa Reductase Inhibitor ◽

Coa Reductase ◽

Drugs Interaction

Download Full-text